Subscribe free

Cytoreductive Surgery & Peritoneum ·

Laparoscopic surgery yields similar outcomes for colorectal peritoneal metastases.

  • Survival rates are comparable: median overall survival is 37.3 months with laparoscopic versus 34.1 months with open surgery.
  • Postoperative complications are similar in both groups, but hospital stays are shorter for laparoscopic patients.
  • Patient selection is crucial; extraperitoneal metastasis significantly impacts survival outcomes.

Consider laparoscopic cytoreductive surgery for suitable patients to enhance recovery without compromising oncologic effectiveness.

Journal Article by Park SY, Kwak SG (…) Choi GS et 7 al. in Surg Endosc

© 2026. The Author(s).

read the whole article in Surg Endosc

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Cytoreductive Surgery & Peritoneum.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Cytoreductive Surgery & Peritoneum

The latest stitches

Ann Surg Oncol28 Aug 2026

Prophylactic HIPEC Improves Survival in Advanced Colorectal Cancer

Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) significantly enhances peritoneal metastasis-free survival and disease-free survival in patients with locally advanced colorectal cancer, though overall survival rates and complication rates remain unchanged.

All papers in Cytoreductive Surgery & Peritoneum →